We have developed robust internal management systems when responding to Drug Recalls which are regularly tested to ensure we have full traceability of products and batches which may be effected.
Domestically we use the Yellow Card Scheme when responding to adverse drug reactions which is also backed up by international pharmacovigilance systems within the countries we supply.